MRAM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MRAM is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading well above its nearby technical support, has no fresh news catalyst, insiders are heavy sellers, and analyst price target was recently cut to $14 even while keeping a Buy rating. The only clearly positive factor is bullish moving averages and favorable option sentiment, but with no Intellectia buy signals and a weak momentum profile, I would not buy it aggressively at this price.
Pre-market price is 31.62, up 1.15%, which shows a mild positive start. The moving average structure is bullish with SMA_5 > SMA_20 > SMA_200, indicating the broader trend remains constructive. However, momentum is weakening: MACD histogram is -0.959 and still expanding lower, while RSI_6 at 48.127 is neutral and not oversold. The stock is above its nearest support at 29.181 and below pivot resistance at 34.632, so it is not at an especially attractive entry point for an impatient buyer. The short-term modeled trend is mixed to mildly positive, with potential for modest gains over a week to a month, but not a strong immediate breakout setup.
Bullish moving average alignment remains intact. Option positioning is strongly call-skewed, suggesting traders are leaning bullish. Pre-market trading is positive. There is no negative news flow in the past week, and there is no recent congress trading activity to suggest an adverse political signal.
No news catalysts in the recent week means there is no fresh event-driven momentum. Insiders are selling, and the selling amount increased 1844.28% over the last month, which is a major negative. Hedge funds are neutral with no significant trading trend. Needham reduced its price target to $14 from $15, which is below the current price and shows valuation skepticism despite maintaining a Buy rating. MACD is weakening, and there is no AI Stock Picker or SwingMax signal today.
Latest quarter financials were not available because the financial snapshot returned an error, so I cannot confirm revenue or earnings growth trends for the latest quarter season.
Needham lowered its price target on Everspin Technologies to $14 from $15 on 2026-03-05 while keeping a Buy rating. That shows analysts remain constructive in rating but less confident in upside, with the target now far below the current trading price. Overall Wall Street view is mixed: the Buy rating is supportive, but the lowered target is a clear con.
